Panacea Biotec shines on receiving order from PAHO for supply of EasyFive-TT Vaccines

04 Feb 2015 Evaluate

Panacea Biotec is currently trading at Rs. 146.60, up by 8.15 points or 5.89% from its previous closing of Rs. 138.45 on the BSE.

The scrip opened at Rs. 140.15 and has touched a high and low of Rs. 151.00 and Rs. 139.95 respectively. So far 39202 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 218.95 on 22-Sep-2014 and a 52 week low of Rs. 89.90 on 14-Mar-2014.

Last one week high and low of the scrip stood at Rs. 145.00 and Rs. 137.00 respectively. The current market cap of the company is Rs. 899.16 crore.

The promoters holding in the company stood at 74.51 % while Institutions and Non-Institutions held 1.94 % and 23.55 % respectively.

Panacea Biotec has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The Company has been awarded for supply of 5.99 Million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 & 2016 worth USD 13.49 Million (equivalent to around Rs 83.52 crore) to meet the requirements of global immunization program.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

563.65 26.60 (4.95%)
29-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.80
Dr. Reddys Lab 1176.25
Cipla 1541.00
Lupin 2067.40
Zydus Lifesciences 887.95
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...